Products Details

  • Shop
  • Brand Details
image
image

Fluarix Tetra Vaccination

2170.00
Availability: In Stock Category: Influenza (Seasonal flu + Swine flu)

Fluarix Tetra – GSK

Indication and Usage –

  • FLUARIX-TETRA is indicated for active immunisation of children from age group 6 months to adults up to 64 years of age for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine.

Dosage and Administration –

  • Immunisation should be carried out by intramuscular injection.
  • For children aged < 9 years, who have not previously been vaccinated against influenza, a second dose should be given after an interval of at least 4 weeks.
  • It is recommended to take each dose annually before monsoon.
  • Children less than 6 months: the safety and efficacy of FLUARIX-TETRA in children less than 6 months have not been established.

Contraindications –

  • Hypersensitivity to the active substances or to any of the excipients or to any component that may be present as traces such as eggs 3 (ovalbumin, chicken proteins), formaldehyde, gentamicin sulphate and sodium deoxycholate.
  • Immunisation shall be postponed in patients with febrile illness or acute infection.

Adverse reactions –

  • In all age groups, the most frequently reported local adverse reaction after vaccination was injection site pain.
  • In adults 18 years of age and above, the most frequently reported general adverse reactions after vaccination were fatigue (11.1%), headache (9.2%) and myalgia (11.8%).
  • In subjects aged 6 to 17 years, the most frequently reported general adverse reactions after vaccination were fatigue (12.6%), myalgia (10.9%) and headache (8.0%).
  • In subjects aged 3 to 5 years, the most frequently reported general adverse reactions after vaccination were drowsiness (9.8%) and irritability (11.3%).
  • In subjects aged 6 months to 3 years, the most frequently reported general adverse reactions after vaccination were irritability/fussiness (14.9%) and loss of appetite (12.9%).

Drug interactions and other interactions –

  • FLUARIX-TETRA can be concomitantly administered with pneumococcal polysaccharide vaccines in subjects aged 50 years and above.
  • The frequency of injection site pain reported in subjects vaccinated concomitantly with inactivated quadrivalent influenza vaccine (FLUARIX-TETRA) and 23-valent pneumococcal polysaccharide vaccine (PPV23) is similar to that observed with PPV23 alone, and higher compared to FLUARIX-TETRA alone.

Inactivated influenza vaccines can be used in all stages of pregnancy. Larger datasets on safety are available for the second and third trimester, compared with the first trimester; however, data from worldwide use of inactivated influenza vaccines do not indicate any adverse foetal and maternal outcomes attributable to the vaccine.

Add a Review

Your email address will not be published. Required fields are marked *